National HIV CurriculumLogo

Lesson 4. Switching or Simplifying Antiretroviral Therapy

 Next Back

Learning Objective Performance Indicators

  • Discuss the rationale for switching or simplifying antiretroviral therapy
  • Describe common situations to consider for simplifying antiretroviral therapy
  • Explain why some antiretroviral medications generally warrant a switch to a newer agent
  • List the two-drug regimens that have been FDA-approved for maintenance antiretroviral therapy
  • Summarize key findings with studies involving a switch to an integrase strand transfer inhibitor

About this Lesson

Learning Objective Performance Indicators

  • Discuss the rationale for switching or simplifying antiretroviral therapy
  • Describe common situations to consider for simplifying antiretroviral therapy
  • Explain why some antiretroviral medications generally warrant a switch to a newer agent
  • List the two-drug regimens that have been FDA-approved for maintenance antiretroviral therapy
  • Summarize key findings with studies involving a switch to an integrase strand transfer inhibitor

Activities in this Lesson

Share by e-mail

Check
-On-
Learning
Questions
The Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.

You must be signed in to customize your interaction with these questions.

The Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS) provided financial support for this website. The award provided 100% of total costs and totaled $1,175,136. The contents are those of the author. They may not reflect the policies of HRSA, HHS, or the U.S. Government.

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.